NCT01562847 Prospective Investigation of Dynamics of ABL Mutations in Imatinib Failed CML Patients Treated With Nilotinib Status UNKNOWN Phase N/A
NCT01559025 Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus Status UNKNOWN Phase PHASE3
NCT01551030 Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium Status COMPLETED Phase PHASE2
NCT01550380 BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers Status WITHDRAWN Phase PHASE2
NCT01549431 Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT01547715 Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India Status COMPLETED Phase PHASE3
NCT01543763 Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01540253 PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or Metastatic Status COMPLETED Phase PHASE1
NCT01532700 An Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) Status COMPLETED Phase PHASE2
NCT01529554 Controlled Level EVERolimus in Acute Coronary Syndromes Status COMPLETED Phase PHASE1/PHASE2
NCT01529450 Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors Status COMPLETED Phase NA
NCT01523977 Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL Status COMPLETED Phase PHASE1
NCT01515969 Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC) Status TERMINATED Phase PHASE1
NCT01515020 Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia Status TERMINATED Phase PHASE3
NCT01512251 BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT01508104 Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT01506596 Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma Status COMPLETED Phase PHASE2